| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.300 | None | 1.000 | 6 | 0 | 2010 | 2017 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 2002 | 2013 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.300 | None | 1.000 | 5 | 0 | 1997 | 2014 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2003 | 2009 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1989 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1988 | 2012 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2004 | 2012 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2016 | 2018 | |||||||||
|
eukaryotic translation initiation factor 3 subunit I | 0.743 | 0.269 | 0.95 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2002 | 2014 | ||||||||
|
programmed cell death 4 | 0.494 | 0.769 | 3.4E-07 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2016 | 2017 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2014 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1995 | 2011 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
microRNA 191 | 0.548 | 0.731 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2018 | |||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1985 | 2011 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2013 | 2018 | ||||||||
|
poly(ADP-ribose) glycohydrolase | 0.656 | 0.500 | 0.39 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2015 | 2016 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2011 | ||||||||
|
paxillin | 0.547 | 0.654 | 8.2E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
protein tyrosine kinase 2 | 0.497 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 |